Teladoc Health, Inc. TDOC
We take great care to ensure that the data presented and summarized in this overview for Teladoc Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TDOC
View all-
Vanguard Group Inc Valley Forge, PA17.3MShares$160 Million0.01% of portfolio
-
Black Rock Inc. New York, NY14.2MShares$132 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.48MShares$69.2 Million0.67% of portfolio
-
Nikko Asset Management Americas, Inc.7.18MShares$66.4 Million1.08% of portfolio
-
State Street Corp Boston, MA6.01MShares$55.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.53MShares$51.2 Million0.13% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.86MShares$45 Million0.02% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.14MShares$38.3 Million0.03% of portfolio
-
First Trust Advisors LP Wheaton, IL3.05MShares$28.2 Million0.05% of portfolio
-
Man Group PLC London, X02.62MShares$24.2 Million0.1% of portfolio
Latest Institutional Activity in TDOC
Top Purchases
Top Sells
About TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Insider Transactions at TDOC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 02
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
442
-0.6%
|
$3,978
$9.39 P/Share
|
|
Jul 01
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,233
+1.65%
|
-
|
|
Jun 04
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
468
-1.69%
|
$5,148
$11.04 P/Share
|
|
Jun 03
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
4,015
-8.87%
|
$44,165
$11.16 P/Share
|
|
Jun 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,040
-1.42%
|
$11,440
$11.16 P/Share
|
|
Jun 03
2024
|
James L. Cave INTERIM CAO |
SELL
Open market or private sale
|
Direct |
854
-6.41%
|
$9,394
$11.16 P/Share
|
|
Jun 03
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,096
-3.37%
|
$23,056
$11.16 P/Share
|
|
Jun 03
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,790
-5.94%
|
$19,690
$11.16 P/Share
|
|
Jun 03
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,122
-3.89%
|
$12,342
$11.16 P/Share
|
|
Jun 03
2024
|
Laizer Kornwasser PRESIDENT, ENTERPRISE GROWTH |
SELL
Open market or private sale
|
Direct |
4,812
-5.04%
|
$52,932
$11.16 P/Share
|
|
Jun 03
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,246
-5.8%
|
$46,706
$11.16 P/Share
|
|
Jun 03
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,627
-4.14%
|
$17,897
$11.16 P/Share
|
|
Jun 03
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,807
-4.15%
|
$19,877
$11.16 P/Share
|
|
Jun 03
2024
|
Mala Murthy ACTING CEO, CFO |
SELL
Open market or private sale
|
Direct |
8,807
-10.06%
|
$96,877
$11.16 P/Share
|
|
May 31
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
7,803
+5.67%
|
-
|
|
May 31
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,854
+0.97%
|
-
|
|
May 31
2024
|
James L. Cave INTERIM CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,885
+5.49%
|
-
|
|
May 31
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,768
+3.06%
|
-
|
|
May 31
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+5.38%
|
-
|
|
May 31
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,407
-10.56%
|
$37,477
$11.21 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 797K shares |
|---|
| Open market or private sale | 432K shares |
|---|---|
| Bona fide gift | 49.1K shares |